Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001
- Caroline E. McCoach
- , Christian Rolfo
- , Alexander Drilon
- , Mario Lacouture
- , Benjamin Besse
- , Koichi Goto
- , Viola W. Zhu
- , Daniel S.W. Tan
- , Stephanie Farajian
- , Laura A. Potter
- , Jennifer F. Kherani
- , Victoria Soldatenkova
- , Elizabeth A. Olek
- , Catherine E. Muehlenbein
- , Keunchil Park
- University of California at San Francisco
- Genentech, Inc
- University of Maryland School of Medicine
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan-Kettering Cancer Center
- Gustave Roussy
- National Cancer Center Japan
- University of California at Irvine
- Duke-NUS Medical School
- University of California at Davis
- Eli Lilly
Research output: Contribution to journal › Article › peer-review
42
Link opens in a new tab
Scopus
citations